Form 8-K - Current report:
SEC Accession No. 0001213900-26-075013
Filing Date
2026-07-02
Accepted
2026-07-02 16:30:21
Documents
16
Period of Report
2026-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0296868-8k_ostherapies.htm   iXBRL 8-K 72744
2 FORM OF SENIOR SECURED CONVERTIBLE PROMISSORY NOTE ea029686801ex4-1.htm EX-4.1 140307
3 FORM OF COMMON STOCK PURCHASE WARRANT ea029686801ex4-2.htm EX-4.2 67629
4 SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 30, 2026, AMONG OS THERAPIES INC ea029686801ex10-1.htm EX-10.1 173170
5 PLEDGE AND SECURITY AGREEMENT, DATED AS OF JUNE 30, 2026, AMONG OS THERAPIES INC ea029686801ex10-2.htm EX-10.2 96357
6 PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON JULY 2, 2026 ea029686801ex99-1.htm EX-99.1 19871
  Complete submission text file 0001213900-26-075013.txt   889985

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ostx-20260630.xsd EX-101.SCH 3023
8 XBRL LABEL FILE ostx-20260630_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE ostx-20260630_pre.xml EX-101.PRE 22364
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0296868-8k_ostherapies_htm.xml XML 3339
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 261151845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)